John M. Wesolowski - 29 Jun 2023 Form 3 Insider Report for INTENSITY THERAPEUTICS, INC. (INTS)

Role
Interim CFO
Signature
/s/ Daniel L. Woodard, Attorney-in-Fact
Issuer symbol
INTS
Transactions as of
29 Jun 2023
Transactions value $
$0
Form type
3
Filing time
29 Jun 2023, 19:57:17 UTC
Next filing
21 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding INTS Common Stock, $0.0001 Par Value 5K 29 Jun 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INTS Stock Option (right to buy Common Stock) 29 Jun 2023 Common Stock 15K $4.00 Direct F1
holding INTS Stock Option (right to buy Common Stock) 29 Jun 2023 Common Stock 7.5K $8.00 Direct F1
holding INTS Stock Option (right to buy Common Stock) 29 Jun 2023 Common Stock 2.5K $9.00 Direct F2
holding INTS Stock Option (right to buy Common Stock) 29 Jun 2023 Common Stock 6.25K $11.50 Direct F3
holding INTS Stock Option (right to buy Common Stock) 29 Jun 2023 Common Stock 6K $11.50 Direct F4
holding INTS Stock Option (right to buy Common Stock) 29 Jun 2023 Common Stock 6.5K $11.50 Direct F5
holding INTS Stock Option (right to buy Common Stock) 29 Jun 2023 Common Stock 12.5K $9.00 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested and exercisable.
F2 This option is vested and exercisable with regard to 1,875 shares of Common Stock. This option will vest with regard to the remaining shares of Common Stock, subject to the individual's continued employment with Intensity Therapeutics, Inc., on July 11, 2023.
F3 This option is vested and exercisable with regard to 3,125 shares of Common Stock. This option will vest with regard to the remaining shares of Common Stock, subject to the individual's continued employment with Intensity Therapeutics, Inc., in two equal annual installments, beginning on July 31, 2023.
F4 This option is vested and exercisable with regard to 1,500 shares of Common Stock. This option will vest with regard to the remaining shares of Common Stock, subject to the individual's continued employment with Intensity Therapeutics, Inc., in three equal annual installments, beginning on August 13, 2023.
F5 This option is vested and exercisable with regard to 1,625 shares of Common Stock. This option will vest with regard to the remaining shares of Common Stock, subject to the individual's continued employment with Intensity Therapeutics, Inc., in three equal annual installments, beginning on September 5, 2023.
F6 This option will vest with regard to the remaining shares of Common Stock, subject to the individual's continued employment with Intensity Therapeutics, Inc., in four annual installments, beginning on December 13, 2023.

Remarks:

Exhibit 24 - Power of Attorney